PMID- 1873433
OWN - NLM
STAT- MEDLINE
DCOM- 19910925
LR  - 20200304
IS  - 0957-5243 (Print)
IS  - 0957-5243 (Linking)
VI  - 2
IP  - 1
DP  - 1991 Jan
TI  - The epidemiology of HTLV-I infection.
PG  - 37-52
AB  - It has been 10 years since the discovery of the human T-cell lymphotropic virus 
      type I (HTLV-I), the first human retrovirus. During the past decade, significant 
      progress has been made in understanding the transmission of the virus and 
      defining its geographic distribution. It has been shown conclusively that HTLV-I 
      is a causal factor in the induction of both adult T-cell leukemia/lymphoma and 
      HTLV-I-associated myelopathy. However, the pathogenesis of each of these 
      conditions is not clear, and in the light of the evidence of immune dysfunction 
      seen among carriers of the infection, it is likely that other associated diseases 
      will be identified. The challenge in the next decade will be to develop and 
      implement therapeutic interventions among carriers to prevent such diseases as 
      well as to curtail transmission within endemic populations.
FAU - Mueller, N
AU  - Mueller N
AD  - Department of Epidemiology, Harvard School of Public Health, Boston, MA 02115.
LA  - eng
GR  - R37CA38450/CA/NCI NIH HHS/United States
PT  - Journal Article
PT  - Research Support, Non-U.S. Gov't
PT  - Research Support, U.S. Gov't, P.H.S.
PT  - Review
PL  - Netherlands
TA  - Cancer Causes Control
JT  - Cancer causes & control : CCC
JID - 9100846
SB  - IM
MH  - HTLV-I Infections/*epidemiology/transmission
MH  - Humans
MH  - Leukemia-Lymphoma, Adult T-Cell/epidemiology/physiopathology
MH  - Paraparesis, Tropical Spastic/epidemiology/physiopathology
RF  - 185
EDAT- 1991/01/01 00:00
MHDA- 1991/01/01 00:01
CRDT- 1991/01/01 00:00
PHST- 1991/01/01 00:00 [pubmed]
PHST- 1991/01/01 00:01 [medline]
PHST- 1991/01/01 00:00 [entrez]
AID - 10.1007/BF00052359 [doi]
PST - ppublish
SO  - Cancer Causes Control. 1991 Jan;2(1):37-52. doi: 10.1007/BF00052359.